The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.
- Pass H Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, New York. Electronic address: harvey.pass@nyumc.org.
- Giroux D Cancer Research And Biostatistics, Seattle, Washington.
- Kennedy C University of Sydney, Putney, New South Wales, Australia.
- Ruffini E Thoracic Surgery, University of Turin, Chieri, Italy.
- Cangir AK Department of Thoracic Surgery, Ankara University Faculty of Medicine, Ankara, Turkey.
- Rice D Department of Thoracic Surgery, M. D. Anderson Cancer Center, Houston, Texas.
- Asamura H National Cancer Center, Keio University School of Medicine, Tokyo, Japan.
- Waller D Glenfield Hospital, Groby Road, Leicestershire, United Kingdom.
- Edwards J Sheffield Teaching Hospital, Department of Cardiothoracic Surgery, Sheffield, United Kingdom.
- Weder W Division of Thoracic Surgery, University Hospital, Zurich, Switzerland.
- Hoffmann H Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
- van Meerbeeck JP Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.
- Nowak A University of Western Australia, Subiaco, Western Australia, Australia.
- Rusch VW Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- 2016-09-28
Published in:
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. - 2016
Mesothelioma
Registry
Staging
TNM
Humans
Lung Neoplasms
Mesothelioma
Neoplasm Staging
Pleural Neoplasms
Rare Diseases
Registries
English
For nearly 40 years, there was no generally accepted staging system for malignant pleural mesothelioma. In 1994, members of the International Mesothelioma Interest Group, in collaboration with the International Association for the Study of Lung Cancer, proposed a TNM staging system based on analyses of outcomes in retrospective surgical series and small clinical trials. Subsequently accepted by the American Joint Commission on Cancer and the Union for International Cancer Control for the sixth editions of their staging manuals, this system has since been the international staging standard. However, it has significant limitations, particularly with respect to clinical staging and to the categories for lymph node staging. Here we provide an overview of the development of the International Association for the Study of Lung Cancer malignant pleural mesothelioma staging database, which was designed to address these limitations through the development of a large international data set. Analyses of this database, described in papers linked to this overview, are being used to inform revisions in the eighth editions of the American Joint Commission on Cancer and Union for International Cancer Control staging systems.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1016/j.jtho.2016.09.123
- PMID 27670823
- Persistent URL
- https://sonar.ch/global/documents/9653
Statistics
Document views: 22
File downloads:
- fulltext.pdf: 0